David C. Henderson, MD, currently serves as Psychiatrist-in-Chief, Division of Psychiatry, at Boston Medical Center and Professor and Chair, Department of Psychiatry, at Boston University School of Medicine. Dr. Henderson previously served as Director of The Chester M. Pierce, MD Division of Global Psychiatry at Massachusetts General Hospital (MGH), Director of the MGH Schizophrenia Clinical and Research Program, and Medical Director of the Harvard Program in Refugee Trauma. Dr. Henderson serves as Co-Director of the NIMH T32 MGH-BUSM Global Mental Health Clinical Research Fellowship. He has worked internationally for the past 21 years in resource-limited settings, and areas impacted by mass violence, disasters and complex emergencies. Dr. Henderson has conducted research and training programs in Bosnia, Cambodia, East Timor, Ethiopia, Haiti, Liberia, New Orleans, New York City, Rwanda and Peru, South Africa, and Somaliland among other places. His work has consisted of field studies, needs assessments, mental health policy development and strategic planning, quantitative and qualitative surveys, mental health capacity building programs for specialized and primary health professionals, and skill-transfer program evaluation. In the United States, he has conducted more than 30 randomized clinical trials in severely mentally ill populations. Dr. Henderson has also directed a schizophrenia research training fellowship, and mentored trainees and junior faculty who have progressed to K awards and secured other independent funding. He actively mentors 10 psychiatry residents and 4 postdoctoral fellows on data-driven international research projects
- Chair, Psychiatry, Boston University School of Medicine
- Assistant Dean, Diversity & Multicultural Affairs, Boston University School of Medicine
- University of Massachusetts Medical School, MD
- Tufts University, BS
- Published on 2/12/2019
Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Feb 12. PMID: 30747254.
- Published on 1/1/2019
Oppenheim CE, Axelrod K, Menyongai J, Chukwuezi B, Tam A, Henderson DC, Borba CPC. The HEAAL Project: Applying Community-Based Participatory Research (CBPR) Methodology in a Health and Mental Health Needs Assessment With an African Immigrant and Refugee Faith Community in Lowell, Massachusetts. J Public Health Manag Pract. 2019 Jan/Feb; 25(1):E1-E6. PMID: 30507809.
- Published on 12/15/2018
Pino EC, Zuo Y, Schor SH, Zatwarnicki S, Henderson DC, Borba CP, Milanovic SM, Kalesan B. Temporal trends of co-diagnosis of depression and/or anxiety among female maternal and non-maternal hospitalizations: Results from Nationwide Inpatient Sample 2004-2013. Psychiatry Res. 2019 02; 272:42-50. PMID: 30579180.
- Published on 12/1/2018
Levey EJ, Laird LD, Becker AE, Harris BL, Lekpeh GG, Oppenheim CE, Henderson DC, Borba CPC. Narratives of Agency and Capability from Two Adolescent Girls in Post-conflict Liberia. Cult Med Psychiatry. 2018 Dec; 42(4):947-979. PMID: 30076558.
- Published on 11/13/2018
Pino EC, Zuo Y, Borba CP, Henderson DC, Kalesan B. Reply to psychiatric disorders' paradoxical protective effect on cardiovascular procedures and mortality. Psychiatry Res. 2018 12; 270:1181-1183. PMID: 30470578.
- Published on 3/20/2018
Pino EC, Zuo Y, Borba CPC, Henderson DC, Kalesan B. Clinical depression and anxiety among ST-elevation myocardial infarction hospitalizations: Results from Nationwide Inpatient Sample 2004-2013. Psychiatry Res. 2018 08; 266:291-300. PMID: 29615266.
- Published on 3/15/2018
Petruzzi LJ, Pullen SJ, Lange BCL, Parnarouskis L, Dominguez S, Harris B, Quiterio N, Lekpeh G, Manobah B, Henderson DC, Borba CPC. Contributing Risk Factors for Substance Use Among Youth in Postconflict Liberia. Qual Health Res. 2018 10; 28(12):1827-1838. PMID: 29542398.
- Published on 3/9/2018
Chouinard VA, Henderson DC, Dalla Man C, Valeri L, Gray BE, Ryan KP, Cypess AM, Cobelli C, Cohen BM, Öngür D. Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis. Mol Psychiatry. 2018 Mar 09. PMID: 29523870.
- Published on 11/23/2017
Jackson JW, Fulchino L, Rogers J, Mogun H, Polinski J, Henderson DC, Schneeweiss S, Fischer MA. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients". Pharmacoepidemiol Drug Saf. 2018 Jan; 27(1):95-104. PMID: 29168261.
- Published on 11/22/2017
Nemani KL, Greene MC, Ulloa M, Vincenzi B, Copeland PM, Al-Khadari S, Henderson DC. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. Clin Schizophr Relat Psychoses. 2019; 12(4):168-176. PMID: 29164928.
View 137 more publications: View full profile at BUMC